AbbVie Inc. (ABBV)

Basic

  • Market Cap

    $261.25B

  • EV

    $309.17B

  • Shares Out

    1,765.54M

  • Revenue

    $55.14B

  • Employees

    50,000

Margins

  • Gross

    69.92%

  • EBITDA

    50.77%

  • Operating

    34.85%

  • Pre-Tax

    14.51%

  • Net

    11.81%

  • FCF

    44.85%

Returns (5Yr Avg)

  • ROA

    9.99%

  • ROE

    -18.76%

  • ROCE

    20.63%

  • ROIC

    19.71%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $167.53

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $31.17

  • Earnings (Dil)

    $3.65

  • FCF

    $13.94

  • Book Value

    $6.85

Growth (CAGR)

  • Rev 3Yr

    10.7%

  • Rev 5Yr

    11.37%

  • Rev 10Yr

    11.31%

  • Dil EPS 3Yr

    -7.21%

  • Dil EPS 5Yr

    -5.27%

  • Dil EPS 10Yr

    2.56%

  • Rev Fwd 2Yr

    -4.22%

  • EBITDA Fwd 2Yr

    -8.48%

  • EPS Fwd 2Yr

    -10.08%

  • EPS LT Growth Est

    0.24%

Dividends

  • Yield

    —

  • Payout

    161.81%

  • DPS

    $5.92

  • DPS Growth 3Yr

    7.84%

  • DPS Growth 5Yr

    10.52%

  • DPS Growth 10Yr

    17.3%

  • DPS Growth Fwd 2Yr

    4.04%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

32,753.0

33,266.0

45,804.0

56,197.0

58,054.0

55,138.0

Total Revenues % Chg.

16.1%

1.6%

37.7%

22.7%

3.3%

-4.6%

Cost of Goods Sold, Total

7,718.0

7,439.0

15,257.0

16,114.0

16,527.0

16,585.0

Gross Profit

25,035.0

25,827.0

30,547.0

40,083.0

41,527.0

38,553.0

Selling General & Admin Expenses, Total

7,353.0

6,763.0

9,867.0

11,872.0

12,084.0

12,453.0

R&D Expenses

5,259.0

5,377.0

6,003.0

6,820.0

6,487.0

6,897.0

Other Operating Expenses

500.0

-560.0

—

500.0

-1.0

-11.0

Other Operating Expenses, Total

13,112.0

11,580.0

15,870.0

19,192.0

18,570.0

19,339.0

Operating Income

11,923.0

14,247.0

14,677.0

20,891.0

22,957.0

19,214.0

Interest Expense, Total

-1,348.0

-1,784.0

-2,454.0

-2,423.0

-2,230.0

-2,226.0

Interest And Investment Income

204.0

275.0

174.0

39.0

186.0

444.0

Net Interest Expenses

-1,144.0

-1,509.0

-2,280.0

-2,384.0

-2,044.0

-1,782.0

Currency Exchange Gains (Loss)

-24.0

-42.0

-71.0

-51.0

-148.0

-137.0

Other Non Operating Income (Expenses)

-64.0

9.0

113.0

55.0

142.0

166.0

EBT, Excl. Unusual Items

10,691.0

12,705.0

12,439.0

18,511.0

20,907.0

17,461.0

Restructuring Charges

—

—

—

—

—

—

Merger & Related Restructuring Charges

—

-103.0

-1,912.0

-1,787.0

-768.0

-641.0

Gain (Loss) On Sale Of Investments

—

—

—

—

—

—

Gain (Loss) On Sale Of Assets

—

330.0

—

68.0

172.0

—

Asset Writedown

-5,070.0

-1,030.0

—

—

-876.0

-2,930.0

In Process R&D Expenses

-424.0

-385.0

-1,376.0

-1,124.0

-697.0

-739.0

Legal Settlements

—

—

—

—

-2,500.0

—

Other Unusual Items

—

-3,091.0

-5,753.0

-2,679.0

-2,761.0

-5,148.0

EBT, Incl. Unusual Items

5,197.0

8,426.0

3,398.0

12,989.0

13,477.0

8,003.0

Income Tax Expense

-490.0

544.0

-1,224.0

1,440.0

1,632.0

1,482.0

Earnings From Continuing Operations

5,687.0

7,882.0

4,622.0

11,549.0

11,845.0

6,521.0

Minority Interest

—

—

-6.0

-7.0

-9.0

-7.0

Net Income

5,687.0

7,882.0

4,616.0

11,542.0

11,836.0

6,514.0

Preferred Dividend and Other Adjustments

30.0

40.0

60.0

74.0

54.0

43.0

Net Income to Common Incl Extra Items

5,657.0

7,842.0

4,556.0

11,468.0

11,782.0

6,471.0

Net Income to Common Excl. Extra Items

5,657.0

7,842.0

4,556.0

11,468.0

11,782.0

6,471.0

Total Shares Outstanding

1,478.8

1,478.9

1,765.1

1,768.3

1,769.2

1,765.5

Weighted Avg. Shares Outstanding

1,541.0

1,481.0

1,667.0

1,770.0

1,771.0

1,768.8

Weighted Avg. Shares Outstanding Dil

1,546.0

1,484.0

1,673.0

1,777.0

1,778.0

1,774.3

EPS

3.7

5.3

2.7

6.5

6.7

3.7

EPS Diluted

3.7

5.3

2.7

6.5

6.6

3.7

EBITDA

13,688.0

16,264.0

21,148.0

29,412.0

31,424.0

27,993.0